Delivery Order 75A50122D00002-75A50124F61012
Award Date 2/21/24
Potential Completion Date 5/21/27
Potential Value $14M
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is for the establishment of services to support the storage and stability of AS03 adjuvant manufactured to support the COVID-19 federal response. The contract has a total ceiling value of $11,538,800.00 and is a delivery order awarded to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to government agencies. The contract does not have a set-aside designation and is issued by the Office of the...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a delivery order valued at $7.4 million to GlaxoSmithKline, LLC for storage and stability services related to antigens and adjuvants from prior contracts during Base Period Year 3, with performance in Durham, North Carolina. The award was made on February 21, 2024, under Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75A50122D000002, with an ultimate completion date...
- This federal contract award is for the manufacture of one bulk lot of the antigen AS03 on behalf of the Department of Defense Defense Health Agency. The contract was awarded to Glaxosmithkline, LLC, a pharmaceutical company that has provided a range of pharmaceutical goods and services to U.S. government agencies through various federal contracts and grants. The $8,359,043 firm fixed price delivery order is issued under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite...
- This federal contract award from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) was issued to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, valued at $1,811,664.60, is a delivery order under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract....
- This is a firm fixed-price delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The purpose of this task order is to request the fill/finish of one CGMP adjuvant bulk lot under CLIN 0006E and to fill/finish and release the AS03 drug product. The contract has a ceiling value of $444,568.40 and an ultimate completion date of June 30, 2024. This...
- This is a modification to a $49,999,745.68 firm fixed price delivery order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Glaxosmithkline, LLC. The contract is for the provision of pharmaceutical products including vaccines, antiviral medications, and vaccine adjuvants to support various U.S. government agencies. The contract has no set-aside designation. Glaxosmithkline has a history of providing a range of pharmaceutical products...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a firm fixed-price delivery order valued at $493,470 to GlaxoSmithKline, LLC on March 13, 2026, with completion scheduled for October 29, 2026. The contract calls for two-way immunogenicity testing on existing clinical trial sera to establish immunogenicity superiority of a new vaccine strain versus the prototype strain. The work will be performed in Durham, North...
- This is a delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The purpose of this $8,609,815.00 firm-fixed-price contract modification is to fund Option Year 2 for the production of a CGMP (Current Good Manufacturing Practice) adjuvant at the clinical or commercial scale. The overall contract is part of the Pandemic...
- <p>The Office of the Assistant Secretary for Preparedness and Response issued a $15.4 million delivery order to Glaxosmithkline, LLC on February 27, 2024, under IDIQ contract 75A50122D00002 to establish fill/finish activities for AS03 adjuvant to support the COVID-19 federal response in multi-dose vials for the Department of Health and Human Services.</p> <p>Place of performance is Durham, NC. The order carries a firm fixed price and an ultimate completion date of February 21, 2027.</p>
- This is a modification to a delivery order contract awarded to GlaxoSmithKline, LLC, a foreign-owned, for-profit pharmaceutical company, by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response. The purpose of this modification is to fund Option Year Two of CLIN 2201, which is for CGMP (Current Good Manufacturing Practice) adjuvant production, either at the clinical or commercial scale, with a quantity of 1 and a unit price of...